益胃化瘀方敷脐联合胃复春胶囊治疗脾虚血瘀型慢性萎缩性胃炎伴低级别上皮内瘤变临床研究OA
Clinical Study of Umbilical Application with Yiwei Huayu Prescription Combined with Weifuchun Capsules in Treating Chronic Atrophic Gastritis Complicated by Low-Grade Intraepithelial Neoplasia of Spleen Deficiency and Blood Stasis Type
目的:观察益胃化瘀方敷脐联合胃复春胶囊治疗脾虚血瘀型慢性萎缩性胃炎(CAG)伴低级别上皮内瘤变(LGIN)的临床疗效.方法:选取2024年1月—2025年3月嘉兴市中医医院脾胃病科门诊就诊或住院部收治的脾虚血瘀型CAG伴LGIN患者60例作为研究对象,以随机数字表法分为观察组和对照组各30例;其中对照组剔除1例,最终纳入29例.观察组给予胃复春胶囊口服加益胃化瘀方敷脐治疗;对照组予胃复春胶囊口服.疗程均为12周.观察2组临床疗效及治疗前后中医证候评分、胃黏膜组织总评分及LGIN评分、胃萎缩分期系统/胃肠化生分期系统(OLGA/OLGIM)分期、血清学指标[血清胃蛋白酶原Ⅰ(PGⅠ)、胃蛋白酶原Ⅱ(PGⅡ)、胃蛋白酶原比值(PGR)、胃泌素17(G-17)]水平.结果:治疗后,观察组总有效率为96.7%(29/30),对照组为75.9%(22/29),组间比较,差异有统计学意义(P<0.05).治疗后,2组胃脘疼痛、饱胀感、嗳气、纳差、反酸等中医证候评分均较治疗前降低(P<0.05),且观察组各项评分均低于对照组(P<0.05).治疗后,2组胃黏膜组织总评分及LGIN评分均较治疗前降低(P<0.05),且观察组评分低于对照组(P<0.05).治疗后,2组OLGA、OLGIM分期均较治疗前改善(P<0.05);观察组OLGA分期改善优于对照组(P<0.05),但2组OLGIM分期差异无统计学意义(P>0.05).治疗后,2组PGⅠ、PGR、G-17水平均较治疗前升高(P<0.05),PGⅡ水平均较治疗前降低(P<0.05);且观察组PGⅠ、PGR、G-17水平高于对照组(P<0.05),PGⅡ水平低于对照组(P<0.05).结论:益胃化瘀方敷脐联合胃复春胶囊治疗脾虚血瘀型CAG伴LGIN患者疗效确切,可改善患者临床症状、胃黏膜组织病理学评分、OLGA分期及相关血清学指标.
Objective:To observe the clinical efficacy of umbilical application with Yiwei Huayu Prescription combined with Weifuchun Capsules in treating chronic atrophic gastritis(CAG)complicated by low-grade intraepithelial neoplasia(LGIN)of spleen deficiency and blood stasis type.Methods:A total of 60 patients with CAG complicated by LGIN of spleen deficiency and blood stasis type who visited the outpatient clinic or were admitted to the inpatient department of spleen and stomach diseases at Jiaxing Hospital of Traditional Chinese Medicine from January 2024 to March 2025 were selected as the study subjects.The patients were randomly divided into an observation group and a control group using the random number table method,with 30 cases in each group.One case was excluded from the control group,resulting in 29 cases finally included.The observation group received Weifuchun Capsules orally plus umbilical application with Yiwei Huayu Prescription,while the control group received Weifuchun Capsules orally.Both groups were treated for 12 weeks.Clinical efficacy,traditional Chinese medicine syndrome scores,total histopathological scores of gastric mucosa,LGIN scores,Operative Link on Gastritis Assessment/Operative Link on Gastric Intestinal Metaplasia Assessment(OLGA/OLGIM)stages,and levels of serological indicators[serum pepsinogenⅠ(PGⅠ),pepsinogenⅡ(PGⅡ),pepsinogen ratio(PGR),gastrin-17(G-17)]between the two groups were observed before and after treatment.Results:After treatment,the total effective rate was 96.7%(29/30)in the observation group,significantly higher than that of 75.9%(22/29)in the control group(P<0.05).Traditional Chinese medicine syndrome scores for epigastric pain,bloating,belching,poor appetite,and sour regurgitation decreased in both groups after treatment(P<0.05),with lower scores in the observation group(P<0.05).Total histopathological scores of gastric mucosa and LGIN scores decreased in both groups after treatment(P<0.05),with lower scores in the observation group(P<0.05).OLGA and OLGIM stages improved in both groups after treatment(P<0.05).The improvement in OLGA stage was better in the observation group than in the control group(P<0.05),while no significant difference was observed in OLGIM stages between the two groups(P>0.05).PGⅠ,PGR,and G-17 levels increased in both groups after treatment(P<0.05),while PG Ⅱ levels decreased(P<0.05).The observation group had higher PGⅠ,PGR,and G-17 levels and lower PGⅡ levels than the control group(P<0.05).Conclusion:Umbilical application with Yiwei Huayu Prescription combined with Weifuchun Capsules demonstrates definite efficacy in treating CAG complicated by LGIN of spleen deficiency and blood stasis type,improving clinical symptoms,histopathological scores of gastric mucosa,OLGA staging,and related serological indicators.
沈灵娜;刘军;黄永宏;闫志鹏
嘉兴市中医医院脾胃病科,浙江 嘉兴 314000嘉兴市中医医院脾胃病科,浙江 嘉兴 314000嘉兴市中医医院脾胃病科,浙江 嘉兴 314000嘉兴市中医医院脾胃病科,浙江 嘉兴 314000
医药卫生
慢性萎缩性胃炎低级别上皮内瘤变益胃化瘀方敷脐胃复春胶囊胃蛋白酶原胃黏膜组织病理学评分
Chronic atrophic gastritisLow-grade intraepithelial neoplasiaYiwei Huayu PrescriptionUmbilical applicationWeifuchun CapsulesPepsinogenHistopathological scores of gastric mucosa
《新中医》 2026 (10)
22-28,7
浙江省医学会临床医学专项资金项目(2023ZYC-Z20)嘉兴市顾国柱名中医传承工作室建设项目(2021-MZYGZS-001)
评论